Axq Capital, LP Biocryst Pharmaceuticals Inc Transaction History

Axq Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $37,576 - $44,352	5,600 Added 31.94%	23,134 $164 Million
Q2 2023 Aug 11, 2023	SELL	$6.96 - $8.81 $9,048 - $11,453	-1,300 Reduced 6.9%	17,534 $123 Million
Q1 2023 May 10, 2023	BUY	$7.94 - $11.84 $149,541 - $222,994	18,834 New	18,834 $157 Million

279

169M

930K

1.03M

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.68B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.